ArticleDusunen adam : Bakirkoy Ruh ve Sinir Hastaliklari Hastanesi yayin organi2024
Evaluation of adverse effects during the initial electroconvulsive therapy (ECT) session:A retrospective study from a specialist ECT unit in a mental health hospital.
Article in Dusunen adam : Bakirkoy Ruh ve Sinir Hastaliklari Hastanesi yayin organi, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Characteristics and outcomes of early-terminated acute electroconvulsive therapy courses: A retrospective cohort study.Dusunen adam : Bakirkoy Ruh ve Sinir Hastaliklari Hastanesi yayin organi · 2026Article
- Electroconvulsive Therapy for Obsessive-Compulsive Symptoms in Schizophrenia Spectrum Disorders: A Systematic Review.Cureus · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aims to evaluate the adverse effects observed during the first electroconvulsive therapy (ECT) session at the Bakirkoy Prof. Mazhar Osman Training and Research Hospital for Psychiatry, Neurology, and Neurosurgery. Method: This retrospective study included 1,449 patients who received ECT between January 1, 2015 and December 31, 2017. Data on sociodemographic characteristics, diagnoses, ECT administration details, and adverse effects were collected from patient records. Before each ECT session, patients or their legal representatives provided written informed consent. The study excluded patients with cardiovascular, hepatic, renal, or neuromuscular diseases or unstable medical conditions. Results: During the first ECT session, some patients experienced specific adverse effects. Prolonged seizures occurred in 7.8% of patients, while inadequate seizures were observed in 12.4%. Post-anesthesia recovery issues were reported in 1.0% of patients. Additional minor complications included confusion (0.2%), agitation (0.5%), headache (0.1%), bradycardia (0.7%), and hypersalivation (1.0%). The absence of a seizure (5.4%) or inadequate seizures (12.4%) were documented as undesirable effects. No severe complications were recorded in the patient population studied. Conclusion: While some adverse effects are common, they are generally mild and transient, making ECT a safe and effective treatment option for severe psychiatric disorders. Our findings further highlight that the safety profile is consistent across sexes, reinforcing ECT's broad applicability. Careful monitoring and management of side effects are crucial to maintaining patient safety and optimizing treatment outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.